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A reconstituted transcription system composed of the Rift Valley fever phlebovirus (Bunyaviridae family) proteins L and
N expressed via recombinant vaccinia viruses and an S-like model RNA containing the CAT gene in the antisense orientation,
has been described previously by Lopez et al. ( J. Virol., 1995, 69, 3972–3979). We extended the use of this in vivo system
to determine the sequence at the 3* end of the ambisense S segment recognized by the transcription complex. A mutational
analysis of the sequences at the 3* end of the S-like genomic or antigenomic RNA was undertaken. The data indicated that
the minimal sequence required for transcription resides in the 13 first 3* nucleotides of the genomic or antigenomic RNA.
In these sequences, two regions appeared crucial: the bases at positions 3 to 8 and the purine at position 13. In addition,
the terminal repeat ...GU could be deleted without affecting significantly the template activity of the RNA. These data support
the prime and realign mechanism proposed recently for Bunya- and Arenaviruses q 1997 Academic Press
INTRODUCTION RNA associated with numerous copies of the N protein
and a few copies of the L protein which possesses all
Rift Valley fever (RVF) virus belongs to the Bunyaviridae the motifs of RNA polymerases (Elliott et al., 1992; Muller
family (genus Phlebovirus). This arthropod-borne virus et al., 1994). In addition, the RNPs are circular due to the
which infects both humans and ruminants in Africa (Pe- presence of conserved inverted complementary se-
ters and Meegan, 1989) is considered as an emerging quences at the 3* and 5* termini, which can form a base-
virus (Morse, 1993; Murphy and Nathanson, 1994). Re- paired panhandle structure (for reviews see, Bouloy,
cently, the complete tripartite negative-stranded RNA ge- 1991; Elliott et al., 1991; Schmaljohn, 1996). This double-
nome of the vaccine candidate MP12 (Caplen et al., 1985) stranded structure has been proposed as a signal for
has been cloned and sequenced. The viral complemen- transcription and encapsidation (Raju and Kolakofsky,
tary sense L and M RNAs (cRNA) code, respectively, 1987, 1989).
for the L protein (Muller et al., 1991, 1994) and for the Studies on transcription and replication of negative-
glycoprotein precursor which is cleaved cotransla- stranded RNA viruses have been facilitated recently by
tionally, generating the envelope glycoproteins G1 and the expression of individual viral proteins via recombinant
G2 and the nonstructural proteins 14 and 78 kDa (Collett viruses as well as the use of artificial RNAs synthetized
et al., 1985; Takehara et al., 1989). The S segment utilizes from cDNA constructs mimicking genomic or defective
an ambisense strategy and codes for the nucleoprotein interfering RNA molecules (Luytjes et al., 1989; Pattnaik
N in the 5* half of the viral cRNA and for the nonstructural et al., 1992; Calain and Roux, 1993; De and Banerjee, 1993;
NSs protein in the remaining 5* half of the genomic sense Conzelmann and Schnell, 1994; Dunn et al., 1995; Grosfeld
RNA (Giorgi et al., 1991). The two open reading frames et al., 1995; Stillman et al., 1995; Yu et al., 1995). We have
are spanned by a short intergenic region rich in C resi- recently established an in vivo system which permits the
dues. The role of the NSs protein is still undetermined. transcription of cDNA-derived RNA templates. It is based
Negative-stranded RNA viruses share a characteristic on an S-like genomic RNA molecule containing the Chlor-
feature by using the viral ribonucleoprotein (RNP), but amphenicol Acetyltransferase (CAT) reporter gene in the
not naked RNA, as a template for transcription and repli- antisense orientation flanked by the 3* and 5* noncoding
cation. Ribonucleoproteins of members of the Bunyaviri- region of the S genome segment (Lopez et al., 1995).
dae family are composed of the genomic or antigenomic Transcription was monitored by assaying CAT activity in
cells transfected with the CAT RNA and coinfected with
vaccinia viruses expressing the L and N proteins. In this1 Present address: Instituto Nacional de Microbiologia ‘‘Dr Carlos G.
minimal system for transcription, the NSs protein ap-Malbran’’, Buenos Aires, Argentina.
peared to have no inhibitory or stimulating effect. In the2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (33) 1 40 61 31 51. E-mail: mbouloy@pasteur.fr. present study, we extended the use of this reconstituted
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transcription system to determine the signal present at In vitro synthesis of S-like RNA
the 3* end of the RNA template which is required for
Two types of DNAs were utilized as templates for RNAtranscription. Transcription of the S ambisense segment
synthesis: plasmid pCAT-RFV-Sg and PCR amplificationresults in the synthesis of two mRNAs: the subgenomic
products. Before transcription, plasmid pCAT-RFV-SgNSs mRNA is synthetized from the antigenome, whereas
was linearized by a digestion with BssHII or BclI andthe antigenomic sense N mRNA is transcribed from the
treated (or not) with nuclease S1 to eliminate the protrud-S genome. Thus, we addressed the question of whether
ing nucleotides. RNA synthesis was carried out essen-the signal for transcription of the genome is identical or
tially as described by Lopez et al. (1995) using the T7 RNAsimilar to that one present in the antigenome. To this end,
polymerase (Pharmacia, Sweden) and the DNA templatewe introduced mutations in the 3* noncoding regions of
was extensively digested by RNase-free DNase I (20the S-like genomic and antigenomic RNAs and tested the
units; Boehringer Mannheim, Germany). The RNA tran-template activity of the RNAs. Altogether, the results indi-
scripts were phenol-chloroform extracted, ethanol pre-cate that the signals present at the 3* ends of the S ge-
cipitated, and the excess of ribonucleotides triphosphatenome and the antigenome are similar and reside in the
was removed by centrifugation through a G25 fine spinsequence of the 13 terminal nucleotides.
column. The amount of RNA was estimated by measuring
the optical density (1 OD unit at 260 mm represents 40
MATERIALS AND METHODS
mg/ml) and the size of the RNA was checked after migra-
tion in an agarose gel.Viruses and cells
Hela S3 cells (ATCC No. CCL-2.2) and CV1 cells (ATCC Transfection of RNAs
No. CCL-70) were grown at 377 in DMEM (Gibco-BRL,
In vitro-synthesized RNA (2 mg) was transfected withLife Technologies, UK) containing 5% fetal calf serum
DOTAP (Boehringer Mannheim, Germany), into freshly(Boehringer Mannheim, Germany). Stocks of wild-type
seeded monolayers of CV1 cells (approx. 106 cells) coin-vaccinia virus (Copenhagen strain) and N and L protein
fected with the two recombinant vaccinia viruses ex-expressing recombinant vaccinia viruses were prepared
pressing RVF virus N and L proteins or the wild-typeby infecting Hela S3 cells at a m.o.i. of 1, according to
vaccinia virus, as already described by Lopez et al.the guideline protocol published by Ausubel et al. (1987).
(1995). All the experiments were carried out in OPTIMEM
(Gibco BRL, Life Technologies, UK). The cell lysate wasConstruction of plasmids
prepared at 48 hr p.i., after 3 cycles of freezing/thawing
Two plasmids, pCAT-RVF-Sg and pCAT-RFV-Sag were and centrifugation to eliminate cellular debris.
used to synthesize S-like RNAs mimicking the genome
and the antigenome, respectively. Plasmid pCAT-RFV-Sg CAT assay
was already described by Lopez et al. (1995) as
The CAT activity was assayed as originally describedpS.NC.CATanti 46 but was renamed for clarity.
by Ausubel et al. (1987). Briefly, in our standard condi-
Synthesis of DNA fragments by PCR tions, the cellular extract corresponding to approximately
105 cells was incubated at 377 for 1 hr in the presence
Polymerase chain reactions (PCR) were performed us-
of 4.2 mM Acetylcoenzyme A (Boehringer Mannheim,
ing 50 ng of plasmid DNA in a 100-ml reaction mix and a
Germany) and 0.02 MBq [14C]chloramphenicol (Amer-
set of two oligonucleotides containing the sequence of
sham Ltd, UK). Under these conditions, the assay was
the T7 promoter and the sequence complementary to the
shown to be in the linear range of the enzymatic activity.
3* end of the S RNA molecule, respectively. The enzymatic
The acetylated forms were analyzed by ascending chro-
reaction was originally carried out with the Vent DNA poly-
matography in a mixture of chloroform (95%) and metha-
merase (New England Biolabs, U.S.A.) to minimize the
nol (5%) as a solvent and quantitated using a PhosphoI-
errors made during the amplification and to avoid the
mager and its software (Molecular Dynamics).
addition of extraneous nucleotides at the 3* end of the
double-stranded DNA. Later on, we employed the Taq Computer analysis
DNA polymerase (Gibco BRL, Life Technologies, UK) and
obtained the same results with either enzyme. After ampli- Multiple sequence alignments were performed by us-
ing the CLUSTAL W software described by Thompson etfication, the ends of the DNA fragments were repaired with
the Klenow enzyme according to the protocol described by al. (1994). All the sequences were taken from the latest
release of the GenBank and EMBL nucleotide sequencePerbal (1988) and the DNA molecules purified in agarose
gels by the Geneclean procedure (Bio 101, U.S.A.). The databases of the GCG package (Devereux et al., 1984).
The abbreviations and the accession numbers are: RVFlist of the oligonucleotides used to generate the wild-type
and mutated CAT RNAs is reported in Table 1. (Rift Valley fever virus, MP12 strain; S segment, X53771;
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FIG. 1. (A) Schematic representation of the two plasmids used as templates for RNA synthesis or amplification of the CAT region by PCR. The
oligonucleotides P5* and P3* or O5* and O3* are indicated. The 3* terminal sequences of RNA synthetized from pCAT RVF-Sg linearized with BclI
and treated or not with nuclease S1 or BssHII were reported. (B) CAT assay from extracts of CV1 cells coinfected with the wild-type vaccinia virus
(lanes 1 and 2) or the recombinant vaccinia viruses expressing RVF virus N and L proteins (lanes 3–6) which were transfected with RNA CAT Sg
synthesized in vitro from pCAT RVF-Sg linearized with BclI (lane 6), with BclI and treated with nuclease S1 (lanes 2 and 4), with BssHII (lane 5), or
from a PCR product obtained using oligonucleotides PROM F10 and Sg wt3* (lanes 1 and 3).
M segment, M25276; L segment, X56464); Tos (Toscana duced at the 3* end of the 3* RVF virus noncoding region
allowing synthesis of a T7 run-off transcript with the au-virus; S, X53794; M, X89628; L, X68414); PT (Punta Toro
virus; S, K02736; M, M11156); SSF (Sicilian Sandfly fever thentic sequence. This was achieved after linearizing the
DNA by a digestion with BclI followed by a treatmentvirus; S, J0441); UUK (Uukuniemi virus, S, M33551; M,
M17417; L, D10759). The FOLDRNA software (Zuker and with nuclease S1 to eliminate the protruding nucleotides.
To facilitate the production of mutant RNA molecules, weStiegler, 1981) of the Genetic Computer Group Package
(University of Wisconsin, U.S.A.) was used to analyze used an alternative method which consists in synthesiz-
ing RNA from a DNA fragment obtained by PCR amplifica-RNA secondary structure predictions.
tion. This DNA product was generated from plasmid
pCAT-RVF-Sg or -Sag using two oligodeoxynucleotides,RESULTS AND DISCUSSION
one containing the F10 promoter followed by the RFV
Synthesis of the RNA molecules utilized as templates virus 5* noncoding sequence and the other correspond-
by the RFV virus transcription complex ing to the sequence complementary to the 3* end ex-
pected in the transcript. The RNA molecules containingFigure 1A shows a schematic representation of the
the wild-type or 3* end mutated sequences were synthe-two plasmids which were used in this study. Plasmid
sized with the appropriate oligodeoxynucleotides (seepCAT-RVF-Sg has been described previously (Lopez et
the list reported in Table 1).al., 1995); it permits in vitro synthesis of a T7 run-off
Figure 1B demonstrates that the T7 transcript gener-transcript representing an S-like genomic RNA with the
ated from the PCR DNA fragment was identical to thecomplete 5* and 3* noncoding sequences of the S ge-
one synthetized directly from plasmid pCAT-RVF-Sg: bothnome and the CAT gene in the antisense orientation.
RNA preparations induced the expression of the CATPlasmid pCAT-RVF-Sag displays the same structure as
enzyme when transfected into CV1 cells coinfected withpCAT-RVF-Sg except that the 5* and 3* noncoding re-
vaccinia viruses expressing the RVF virus L and N pro-gions flanking the CAT gene are those of the antigenomic
teins (lanes 3 and 4) but not in cells infected with wild-S segment. Thus, pCAT-RVF-Sg and pCAT-RVF-Sag allow
type vaccinia virus (lanes 1 and 2). It should be notedsynthesis of an S-like genome and an S-like antigenome,
that the level of CAT expression in the extracts of cellsrespectively.
transfected with the two types of RNA was similar.When plasmids are utilized as templates for in vitro
synthesis of run-off transcripts, the circular DNA must be
Signal for transcription at the 3* end of the S genomelinearized at an appropriate restriction site so that the
RNA molecule contains the desired 3* terminal se- To examine the 3* terminal sequence of the template
recognized by RVF virus transcriptase, a series of muta-quence. In plasmid pCAT-RVF-Sg, a BclI site was intro-
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TABLE 1 still recognized when it was located close to the 3* end
of the template.List of the Oligonucleotides Utilized for Amplification
To determine the role of the 3* terminal nucleotides inof the CAT Gene by PCR
transcription, the RNA template CAT(0)Sg was progres-
Oligonucleotide 3* sively deleted from its nucleotides 1 to 7. The results
shown in Figs. 2A and 2C indicate that the RNA templates
Sg-wt3* ACACAAAGCTCCCTAGAGATACAAACAC
lacking one or two nucleotides at the 3* end could beSg-D1 CACAAAGCTCCCTAGAG
transcribed but the deletion of the first three (or more)Sg-D2 ACAAAGCTCCCTAGAGA
Sg-D3 CAAAGCTCCCTAGAGAT nucleotides is deleterious. These data suggest that the
Sg-D4 AAAGCTCCCTAGAGATA nucleotides at positions 1 and 2 do not represent a strong
Sg-D5 AAGCTCCCTAGAGATAC signal but that the region starting at position 3 and up-
Sg-D6 AGCTCCCTAGAGATACA
stream is essential for the polymerase entry or activity.Sg-D7 GCTCCCTAGAGATACAAACA
To determine more precisely the sequence requiredSg-D25 CACTATTACAATAATGGA
Sg-D20 ACAAACACTATTACAATAATGG for transcription, we reasoned that it must function not
Sg-D25 / 7 ACACAAACACTATTACAATAATGG only in its own context but also when it is linked with
Sg-D25 / 8 ACACAAAGCACTATTACAATAATGG heterologous sequences, provided it is located at (or
Sg-D25 / 13 ACACAAAGCTCCCCACTATTACAATA
close to) the 3* terminus. Interestingly, it was noted thatSg-T13 ACACAAAGCTCCATAGAGATACAAACAC
the sequence at position 25 to 21 (5*...UUUGU...3*) re-Sg-C13 ACACAAAGCTCCGTAGAGATACAAACAC
Sg-A13 ACACAAAGCTCCTTAGAGATACAAACAC sembles the sequence at the extremity ...UUUGUGU-
Sg-A14 ACACAAAGCTCCCTCACTATTACAATAATGGA 3*OH. Since the penultimate GU was not found to be
Sg-C14 ACACAAAGCTCCCGCACTATTACAATAATGGA essential when present in its natural context, we tested
Sg-T14 ACACAAAGCTCCCACACTATTACAATAATGGA
the RNAs CAT(0)Sg D20 and CAT(0)Sg D25 for theirSag-Wt3* ACACAAAGACCCCCTAGTGCTTATC
capacity to serve as templates. No CAT activity was de-Sag-D17 TGCTTATCAAGTATATC
Sag-D17 / 11 ACACAAAGACCTGCTTATCAAGTATA tected in cell extracts coinfected with the two recombi-
Sag-D17 / 13 ACACAAAGACCCCTGCTTATCAAGTATA nant viruses and transfected with either RNA molecule
Sag/Mag ACACAAAGACCGGCTAGTGCTTATCAAG (Figs. 2B and 2C). We tested also whether the sequence
Sag/Lag ACACAAAGACCGCCTAGTGCTTATCAAG
...UUUGUGU plays an important role but no CAT activitySagD2 ACAAAGACCCCCTAGTG
was found in cells transfected with RNA CAT(0)Sg
Oligonucleotide 5* D25/7, suggesting that the sequence of the first seven
PROM.F10* CGCTAATACGACTCACTAT
nucleotides does not represent the signal for transcrip-
tion. Thus, RNA CAT(0)Sg D25 was utilized as the recipi-Note. Sequences are reported from 5* to 3* ends. The sequence of
the F10 promoter is underlined. ent molecule to fuse the putative signal sequence at its
3* end and generate an RNA which was assayed for its
template activity.
The alignment of the RVF virus sequences with thetions was introduced in the S-like genomic RNA template.
The template activity of the mutated molecules was de- sequences published for other members of the phlebo-
virus genus is presented in Fig. 3A. It shows that thetermined by measuring the CAT activity in CV1 cells
transfected with the RNA and infected by the two vaccinia terminal 8 nucleotides of the 3* extremity 5*...CUNU-
GUGU-3* are conserved except for position 6 which is aviruses expressing RVF virus N and L proteins. In the
control experiments, the transfected cells were infected U for RFV, Uukuniemi, and sandfly fever virus but is vari-
able (C or A) in other phlebovirus sequences. It is note-with the wild-type vaccinia virus. Each mutated RNA was
assayed in several independent experiments in which worthy that the purine at position 13 is also conserved.
Thus, the sequence of the 8 or 13 nucleotides presentthe RNA templates were obtained from at least two in
vitro reactions and each RNA preparation was tested for at the 3* end of the RVF virus S segment RNA was grafted
onto RNA CAT(0)Sg D25 and the resulting moleculeCAT activity in duplicate or triplicate.
First, we determined whether the promoter is recog- transfected and assayed for transcription. The RNA mole-
cules CAT(0)Sg D25/8 in which the 8 nucleotides werenized when additional nucleotides were present at the
3* end of the model RNA, taking advantage of the pres- fused at the 3* end of RNA CAT(0)Sg D25 were found to
be inactive for transcription whereas the RNA CAT(0)Sgence of the BclI and BssHII sites in pCAT-RVF-Sg to
generate RNA molecules, called RNA CAT(0)Sg, con- D25/13 was transcribed, leading to a level of CAT activ-
ity corresponding to 5.6% of that one induced by the wild-taining 4 and 16 additional nucleotides at their 3* ends,
respectively. CAT activity was observed in cells trans- type RNA (Figs. 2B and 2C).
Since position 14 is occupied by a purine in the wild-fected with the RNA possessing 4 extra nucleotides but
was not when the RNA possessed 16 extra nucleotides type RNA and CAT(0) Sg D25/13, we tested the role of
this base by assaying the template activity of the mutated(Fig. 1B, lanes 5 and 6), indicating that the promoter was
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FIG. 2. Detection of CAT activity after transfection of genome-like RNAs. (A) The 3* terminal sequence of the mutated molecules are reported
and the initiating ATG of the CAT (or the N) gene is boxed. (B) The sequence of interest is magnified and mutations from the authentic sequence
are highlighted. The repeat is underlined. CAT activity was measured as the percentage of monoacetylated forms of Chloramphenicol in the cell
extracts transfected with the mutated RNA compared to the wild-type molecule. The background obtained with the negative control (cells infected
with the wild-type vaccinia virus and transfected with RNA Sg) was subtracted. All the transfections were carried out in duplicate but only one is
shown in the CAT assay. (C) Autoradiogaphy of the chromatogram from extracts of cells infected with the wild-type vaccinia virus and transfected
with RNA Sg (lane 1) or infected with L and N protein expressing vaccinia viruses transfected with Sg (lane 2), SgD1 (lane 3), D2 (lane 4), D3
(lane 5), D25 (lane 6), D25/8 (lane 7), Sg-A13 (lane 8), D25/13 (lane 9), D25/14 (lane 10), D25/14/C (lane 11), and D25/14/U (lane 12).
RNAs CAT(0)Sg D25/14, D25/14/C, and D25/14/U, in nals. CAT expression obtained with RNA D25/14/C or
U was slightly higher than with RNA D25/14, suggestingwhich the 14 base long 3* terminal sequence was grafted
onto RNA CAT(0) Sg D25, nucleotide 14 being either A that sequences upstream from nucleotide 13 modulate
the level of transcription.(wild-type) or modified into C or U, respectively (Figs. 2B
and 2C). CAT activity representing, respectively, 11.4, 18, To assess the role of the conserved purine at position
13, the wild-type RNA CAT(0)Sg was modified so that theand 33% of that one obtained with the wild-type RNA, was
detected in cells transfected with each mutant, indicating G was replaced by one of the three other bases (Fig.
2B). CAT activity was detected after transfection withthat position 14 has a weak role in the transcription sig-
RNA CAT(0)Sg-A13 but not in the extracts of cells trans-
fected with RNA CAT(0)Sg-C13 or CAT(0)Sg-U13. Alto-
gether these results strongly suggest that the minimal
sequence required for transcription (which yields a de-
tectable CAT activity) is included in the first 13 nucleo-
tides of the 3* extremity and that the purine at position
13 is essential.
Signal for transcription at the 3* end of the
S antigenome
During phlebovirus replication cycle, the genomic as
well as the antigenomic S segment are transcribed into
mRNAs. This ambisense strategy led us to assume that
a promoter sequence similar to the one present at the
3* end of the genome must also exist at the 3* end
of the antigenome. Thus, we designed an RNA model
mimicking the S antigenome and determined the se-FIG. 3. Alignment of the 3* terminal sequences of the phlebovirus
quence required for transcription of the S antigenome.genomes and antigenomes: (A) the three segments or (B) only the S
segments. Plasmid pCAT-RVF-Sag (Fig. 1A) was constructed and
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To avoid drastic modifications in the 3* terminal sec-
ondary structure of the RNA template, the complete se-
quence of the wild-type molecule or the mutants was
analyzed by the RNAFOLD software (UWGCG). Therefore
we selected RNA mutants in which the secondary struc-
ture of the 3* end was similar enough to that of the
natural template. These criteria were fulfilled with RNA
CAT(0)Sag D17 in which the 17 terminal nucleotides of
the wild-type molecule were deleted. Figure 4 shows
that, as expected, this deletion abolished the capacity of
the RNA to be transcribed. When this molecule was used
as a backbone to graft the 3* terminal 11- or 13-base-
long antigenomic sequence, the transcription activity
was restored when the 13-, but not 11-, base-long se-
quence was present at the 3* end. This clearly indicates
that the 13-base-long terminal sequence contains the
minimal signal for transcription.
Interestingly, the first 11 bases at the 3* end of the
three RFV virus antigenomes are conserved, whereas
the bases at positions 12 and 13 are GG, CC, and CG
in the S, M, and L segments, respectively (Fig. 3A). Since
both the genomic and antigenomic sequences required
for transcription contained the dinucleotide GG at posi-
tions 12 and 13, and since the purine at position 13 isFIG. 4. Detection of CAT activity after transfection of antigenome-
like RNAs. (A) The 3* terminal sequences of the mutated molecules essential in the genomic sequence, we assessed the
are reported. The sequence of interest is magnified and mutations from importance of the G at position 12 by replacing it by the
the authentic sequence are highlighted. CAT activity was measured as C present in the L and M antigenomes. As shown in
the percentage of monoacetylated forms of Chloramphenicol in the cell
Figs. 4A and 4B, this modification did not affect the tran-extracts transfected with the mutated RNA compared to the wild-type
scription activity of the RNA template while the replace-molecule. All the transfections were carried out in duplicate but only
one is shown in the CAT assay. (B) Autoradiography of the chromato- ment of G13 by C abolished the transcription activity,
gram from extracts of cells infected with the wild-type vaccinia virus confirming that the purine at position 13 is essential also
and transfected with RNA Sag (lane 1) or infected with L and N protein in the antigenomic transcription signal. Like for the ge-
expressing vaccinia viruses transfected with Sag (lane 4), SagD17
nome, the antigenomic signal was also shown to be ac-(lane 2), D17/11 (lane 3), D2 (lane 5), D17/13 (lane 6), Sag/Lag (lane
tive when the two 3* terminal nucleotides GU were miss-7), Sag/Mag (lane 8).
ing (Figs. 4A and 4B).
In summary, these results indicate that in the S ge-used to synthesize PCR fragments containing the T7 pro-
nome and antigenome the first 13 3* terminal nucleotidesmoter sequence. When the RNA CAT(0)Sag was trans-
represent the minimal signal for transcription. The se-fected into CV1 cells expressing the L and N proteins,
quences are similar and read 3*-UGUGUUUC(G/U)(A/G)-CAT activity was detected in the extracts, indicating that
GGG. In both sequences, the G (which could be replacedthe antigenome-like template was efficiently transcribed
by A to some extent) at position 13 is essential andby the viral complex formed in cells expressing the two
the absence of the first one or two nucleotides is notstructural proteins L and N (Figs. 4A and 4B).
deleterious for the trancription activity of the RNA tem-Comparaison of the 3* terminal sequences of the
plate. As a matter of fact, these two nucleotides representphlebovirus S antigenomes indicated that positions 12
the terminal repeat ...GU of the phlebovirus genome se-and 13 are invariably occupied by purines and the first
quence ...CUUUGUGUOH , which has been highlighted re-11 nucleotides are strictly conserved, the first 8 being
cently by Garcin et al. (1995). These authors have pro-identical or similar to those present in the genome (Fig.
posed that hantaviruses and arenaviruses utilize the3B). Considering the results obtained with the S genome,
prime and realign mechanism by initiating with a purinewe evaluated the role of the 11- or 13-base-long se-
at the internal repeat. This mechanism applies also toquence of the RVF virus S antigenome in transcription.
other genera of the Bunyaviridae family and explains theThe demonstration was carried out, as for the genome,
previous data which showed that Germiston bunyavirusby deleting the model template from its 3* end to make
mRNAs synthetized in an in vitro transcription assay con-it deficient for transcription and by grafting the putative
tain one or two extra bases interposed between thesequence at its 3* end with the aim of restoring the
template activity. primer and the viral sequences and which are not derived
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from the host mRNA primer but are templated from the replication occured in our experimental conditions. Two
different approaches were developped to analyze the3* end of the genome (Vialat and Bouloy, 1992). Our data
showing the weak role played by the first dinucleotide of transcription products, either by Northern blot or by RT-
PCR, but no conclusion could be drawn because of athe phlebovirus-conserved sequence provide an indirect
evidence supporting this mechanism and suggest that high background due to traces of DNA which were not
completely eliminated by the DNase treatment after syn-realignment is not an obligatory step. It is of interest to
note that the polymerases of Arena- and Bunyaviridae thesis of the RNA template. In a third attempt, we con-
structed an RNA template containing the CAT gene inwere found to possess two conserved regions called 1
and 2 present at the N terminus of the protein (Muller et the message sense orientation, similar to the template
constructed by Dunn et al. (1995). An increase of CATal., 1994). It might well be that they are implicated in this
mechanism. activity after transfection should indicate that the RNA
was replicated. Unfortunately and unlike in the Buny-Altogether, the data suggest that the sequence recog-
nized by RVF virus transcriptase is composed of two amwera virus system, CAT activity was detected in cells
infected by the wild-type vaccinia virus as well as thoseimportant regions comprised within nucleotides 3 to 8
and nucleotide 13. This also takes into account the re- expressing the RVF virus complex, indicating that a large
part of the transfected RNA was involved in translationsults obtained with (i) RNA Sg D25/8, which possesses
the correct sequence from nucleotides 3 to 8 but a pyrimi- and a very small fraction, if any, would associate with
the viral transcription complex. The differences observeddine at position 13, (ii) RNA Sg D25/7, which, in spite
of a purine at position 13, has a G at position 8, (iii) RNA with the two systems might be explained if the respective
N proteins are expressed at different levels.Sag D17/11, in which position 13 is a C. The tolerance
for variable nucleotides at positions 9 to 12 is inferred It is of note that the sequence present at the 5* end
or the panhandle structure might also be important forfrom the comparison of the sequences of the L and M
segments and confirmed by the transcription activity as- the recognition of the RNA by transcriptase complex.
Disruption of the double-stranded structure by a mis-sociated with RNA Sag/Lag which possesses a C at posi-
tion 12 instead of the G present in both S genome and match at position 12 in the 5* terminus of the Bunyam-
wera virus template led to the loss of transcription activ-antigenome.
The sequence required for transcription would then be: ity. In the case for influenza virus, the most extensively
studied segmented negative-stranded RNA viruses (for







1995), the signal for transcription was shown to lie within
the 12 nucleotides of the 3* terminus, the most important
signal being at positions 9 to 11 (Parvin et al., 1989; LiA similar sequence, in which position 6 was reported as
being U, C, or A (Fig. 3) is present at the 3* end of the and Palese, 1992; Seong and Brownlee, 1992; Piccone
et al., 1993). However, more recently, the enzymatic com-three genomic RNAs and the S antigenome of all the
phleboviruses which have been sequenced. As ex- plex was reconstituted from recombinant proteins (Hu-
ang et al., 1990; de la Luna et al., 1993; Mena et al., 1994)pected, this 13-base-long sequence is not found in the
antigenomes of the nonambisense M segment but, sur- and detailed analyses revealed that the 5* end in the
duplex structure plays a role in the endonuclease activityprisingly, is present in the L antigenomes. This may ex-
plain why some anti-mRNAs were synthetized, as has (Hagen et al., 1994), the binding of the polymerase sub-
unit (Fodor et al., 1993; 1994; Tiley et al., 1994; Cianci etbeen described in La Crosse virus-infected cells (Hacker
et al., 1990). The presence of an active promoter for tran- al., 1995). Development of such assays would help to
further characterize the RVF virus complex.scription might be reminiscent of the existence of an
ancestral L ambisense segment which has evolved in
Bunyaviruses and been conserved in arenaviruses (Iapa- ACKNOWLEDGMENTS
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